A new class of implantable bioelectronics could make one of the most frustrating problems in medical-device care visible from outside the body. Researchers have developed a battery-free, bioresorbable implant that harvests energy from ultrasound while simultaneously reporting its own position, shape, structural damage and gradual disappearance through a visible optical signal. In experiments in mice, the device’s phosphorescent outline could be seen under handheld illumination, allowing investigators to inspect the implant without surgery. The system also generated electrical output, reaching up to 3.6 volts peak-to-peak when exposed to ultrasound at an intensity of 0.5 watts per square centimetre. The study, published in Nature Nanotechnology, points toward transient bioelectronics that do not simply perform a task inside the body but also reveal whether they remain intact and functional.
Implantable electronics are usually hidden once surgeons place them beneath tissue. That makes it difficult to determine whether an implant has shifted, fractured, degraded prematurely or stopped working. In conventional systems, clinicians may need to rely on imaging procedures, indirect physiological measurements or exploratory surgery. Batteries add another layer of difficulty: they have finite lifetimes, can leak, occupy space and often contain components that remain in the body after the intended treatment has ended. A device designed to disappear could avoid a second operation, but only if doctors can determine when it is still functioning and how rapidly it is breaking down. The new implant addresses this monitoring problem by linking the device’s physical appearance to its electrical performance, creating an external visual readout of events normally concealed beneath the skin.
The researchers built the platform around two complementary technologies: triboelectric energy generation and optical phosphorescence. Triboelectric devices produce electrical charge through contact electrification and electrostatic induction. When two materials with different tendencies to gain or lose electrons interact, charge separation can occur. Mechanical motion then changes the arrangement of those charges, producing a usable alternating electrical signal. In this implant, ultrasound supplies the mechanical stimulus. Acoustic waves passing through tissue drive movement within the device, allowing it to generate electricity without an implanted battery or a direct wired connection. The electrical output is therefore activated from outside the body, on demand, rather than being continuously supplied by a stored power source.
The optical component relies on nanoscale iridium(III) complexes, described in the study as iridophosphors. These molecules emit phosphorescent light after absorbing energy from an external source. Unlike ordinary fluorescence, which generally stops almost immediately when excitation ends, phosphorescence can persist for longer periods because the excited state involves a transition that is less likely to release energy instantly. That persistence makes the material useful as a visual reporter: under handheld illumination, the implant produces a recognizable glowing outline that can be observed through the surrounding tissue. Crucially, the optical signal is not merely an identification tag. Because the phosphorescent material is integrated into the device’s structure, changes in the outline can reveal deformation, breakage, fragmentation or resorption.
Selecting a material capable of both emitting light and supporting triboelectric charge generation was a central challenge. The researchers used a data-driven materials-to-device workflow that combined machine-learning-assisted photophysical screening with a selection strategy based on molecular dipole moments. A molecule’s dipole moment describes how electric charge is distributed within it; larger or appropriately oriented dipoles can influence polarization and charge-transfer behavior, properties that are important for triboelectric performance. At the same time, the molecular structure must produce suitable optical behavior and remain compatible with a resorbable implant. By screening candidate iridium(III) compounds computationally and then selecting materials according to their photophysical characteristics and dipole moments, the team sought to optimize two functions at once rather than treating light emission and energy harvesting as separate engineering problems.
The resulting devices were designed to be read through the skin while also converting ultrasound into electrical energy. When illuminated externally, they produced outlines visible to the unaided eye under handheld light. Those outlines provided information about where the implant was located and what its overall morphology looked like. When ultrasound was applied, the triboelectric structure generated up to 3.6 volts peak-to-peak at 0.5 watts per square centimetre. Peak-to-peak voltage represents the difference between the highest positive and lowest negative portions of an alternating electrical waveform, rather than a steady direct-current voltage. The value indicates that the implant can generate a substantial transient electrical signal, although the practical usefulness of that output will depend on the electrical load, operating frequency, coupling through tissue and the requirements of any future therapeutic or sensing circuit.
The most important feature of the system was the relationship between what researchers could see and what the implant could do electrically. In mouse experiments, optical readouts tracked implant position and morphology, while visible structural defects were associated with a loss of electrical output. That correlation turns the implant’s shape into a functional diagnostic signal. A broken or distorted outline is not simply evidence of physical damage; it can indicate that the energy-harvesting mechanism has also been compromised. Such a relationship could help distinguish a device that has naturally resorbed as intended from one that has failed unexpectedly. It could also support timely intervention in applications where an implant is meant to deliver stimulation, power a temporary sensor or assist tissue healing for a defined period.
The researchers followed the implants in living mice for 38 weeks, using the optical signal to monitor integrity and bioresorption over time. Bioresorption means that the implanted material gradually breaks down and is cleared or assimilated by the body, eliminating the need for surgical retrieval. A transient device must balance two opposing requirements: it must remain stable and functional long enough to perform its medical role, yet eventually disappear without leaving a persistent foreign object. Monitoring that transition is difficult when the device is invisible and battery-free. The new approach provides a way to observe the changing implant directly through its emitted pattern, potentially revealing whether degradation is proceeding uniformly or whether structural damage has occurred earlier than expected.
The concept could be especially valuable for temporary medical technologies, including implants intended for short-term electrical stimulation, localized sensing or controlled therapeutic support. A battery-free design reduces the risks associated with leakage and removes one of the major limits on implant lifetime. Ultrasound provides a non-invasive route for delivering mechanical energy through tissue, while optical readout offers a comparatively simple way to inspect the device with external illumination. Yet the work remains an early-stage demonstration in mice. Human tissue is thicker and optically more complex, and the visibility of a phosphorescent signal will depend on implant depth, tissue composition and the intensity and wavelength of the excitation light. Future studies will also need to examine long-term biocompatibility, the fate of the iridium-containing compounds during resorption, manufacturing consistency and whether the generated electrical power is sufficient for specific clinical functions.
Even with those questions unresolved, the platform introduces a significant shift in how transient implants could be designed. Most bioresorbable electronics are engineered primarily to operate and then vanish; their failure or degradation may remain hidden until symptoms appear or the device is examined after removal. This implant is designed to make its own condition observable. Its morphology acts as a physical status display, while its triboelectric response provides a measurable electrical output. By combining molecular materials discovery, ultrasound-driven power generation and visible phosphorescence, the researchers have created an implant that can communicate its state from inside the body without a battery and without a permanent retrieval procedure. If the approach can be adapted for human use, future temporary bioelectronics may not simply disappear on schedule—they may show clinicians exactly how they are performing until the moment they do.
Subject of Research: Battery-free, bioresorbable triboelectric implants with optical monitoring of structural integrity, energy harvesting and resorption
Article Title: Bioresorbable and optically readable triboelectric implants enabled by nanoscale iridophosphors
Article References: Meng, X., Kwon, Y.H., Wang, B. et al. “Bioresorbable and optically readable triboelectric implants enabled by nanoscale iridophosphors.” Nature Nanotechnology (2026). https://doi.org/10.1038/s41565-026-02256-4
Image Credits: AI Generated
DOI: 10.1038/s41565-026-02256-4
Keywords: bioresorbable implants, triboelectric energy harvesting, iridophosphors, implantable bioelectronics, ultrasound power, phosphorescent imaging, transient electronics, molecular dipole moments
Tags: biodegradable implants with phosphorescent signalingbioresorbable medical implantsimplantable bioelectronicsnanoscale iridophosphorsnanotechnology in bioelectronicsnon-invasive implant inspectionoptical readout of implantsself-reporting medical implantstransient bioelectronicsultrasound energy harvestingultrasound-powered bioelectronic deviceswireless implant monitoring
